Scott & Selber Inc. grew its holdings in Thermo Fisher Scientific Inc. (NYSE:TMO) by 1.5% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 8,507 shares of the medical research company’s stock after buying an additional 129 shares during the period. Scott & Selber Inc.’s holdings in Thermo Fisher Scientific were worth $2,498,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also modified their holdings of TMO. Truvestments Capital LLC acquired a new stake in Thermo Fisher Scientific during the first quarter worth about $29,000. Capital Advisors Ltd. LLC increased its position in Thermo Fisher Scientific by 250.0% during the second quarter. Capital Advisors Ltd. LLC now owns 140 shares of the medical research company’s stock worth $41,000 after purchasing an additional 100 shares during the last quarter. Focused Wealth Management Inc acquired a new stake in Thermo Fisher Scientific during the second quarter worth about $44,000. Farmers & Merchants Trust Co of Chambersburg PA increased its position in Thermo Fisher Scientific by 168.0% during the first quarter. Farmers & Merchants Trust Co of Chambersburg PA now owns 201 shares of the medical research company’s stock worth $55,000 after purchasing an additional 126 shares during the last quarter. Finally, Bay Harbor Wealth Management LLC increased its position in Thermo Fisher Scientific by 183.8% during the second quarter. Bay Harbor Wealth Management LLC now owns 227 shares of the medical research company’s stock worth $67,000 after purchasing an additional 147 shares during the last quarter. Institutional investors and hedge funds own 88.21% of the company’s stock.

Several equities research analysts recently issued reports on TMO shares. Barclays set a $330.00 price objective on shares of Thermo Fisher Scientific and gave the stock a “buy” rating in a research report on Monday, July 15th. Wolfe Research began coverage on shares of Thermo Fisher Scientific in a research note on Thursday, May 30th. They set an “outperform” rating for the company. UBS Group increased their target price on shares of Thermo Fisher Scientific from $305.00 to $320.00 and gave the stock a “buy” rating in a research note on Thursday, May 23rd. Argus increased their target price on shares of Thermo Fisher Scientific from $285.00 to $310.00 and gave the stock a “buy” rating in a research note on Wednesday, May 1st. Finally, Needham & Company LLC increased their target price on shares of Thermo Fisher Scientific from $315.00 to $321.00 and gave the stock a “buy” rating in a research note on Thursday, July 25th. Two analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. Thermo Fisher Scientific has a consensus rating of “Buy” and an average target price of $303.17.

In other Thermo Fisher Scientific news, CEO Marc N. Casper sold 50,000 shares of the firm’s stock in a transaction that occurred on Tuesday, July 30th. The shares were sold at an average price of $284.83, for a total transaction of $14,241,500.00. Following the sale, the chief executive officer now owns 342,193 shares of the company’s stock, valued at $97,466,832.19. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CFO Stephen Williamson sold 2,500 shares of the firm’s stock in a transaction that occurred on Monday, June 3rd. The stock was sold at an average price of $268.29, for a total transaction of $670,725.00. Following the sale, the chief financial officer now directly owns 40,029 shares in the company, valued at approximately $10,739,380.41. The disclosure for this sale can be found here. Insiders sold 52,775 shares of company stock valued at $14,986,676 in the last quarter. 0.45% of the stock is owned by insiders.

Shares of NYSE TMO traded up $3.41 during midday trading on Tuesday, hitting $275.41. The company’s stock had a trading volume of 83,970 shares, compared to its average volume of 1,615,221. The company’s fifty day moving average price is $288.55. The company has a debt-to-equity ratio of 0.58, a current ratio of 1.49 and a quick ratio of 1.07. Thermo Fisher Scientific Inc. has a 1 year low of $208.34 and a 1 year high of $305.45. The stock has a market capitalization of $110.68 billion, a price-to-earnings ratio of 24.77, a price-to-earnings-growth ratio of 1.81 and a beta of 1.11.

Thermo Fisher Scientific (NYSE:TMO) last issued its quarterly earnings results on Wednesday, July 24th. The medical research company reported $3.04 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.01 by $0.03. Thermo Fisher Scientific had a net margin of 14.24% and a return on equity of 17.11%. The company had revenue of $6.32 billion during the quarter, compared to the consensus estimate of $6.31 billion. During the same quarter in the previous year, the firm earned $2.75 earnings per share. The firm’s quarterly revenue was up 3.9% on a year-over-year basis. As a group, equities analysts forecast that Thermo Fisher Scientific Inc. will post 12.23 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, October 15th. Investors of record on Tuesday, September 17th will be paid a $0.19 dividend. The ex-dividend date is Monday, September 16th. This represents a $0.76 dividend on an annualized basis and a yield of 0.28%. Thermo Fisher Scientific’s dividend payout ratio is currently 6.83%.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc provides analytical and other instruments, laboratory equipment, software, consumables, reagents, instrument systems, chemicals, supplies, and services under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide.

Featured Article: Straddles

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.